Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16708504 | 0.82 | POLRMT (0.68) | POLRMTDOT1L | |
| SCHEMBL19778886 | 0.82 | POLRMT (0.68) | POLRMTDOT1L | |
| SCHEMBL13486311 | 0.82 | POLRMT (0.61) | POLRMTDOT1L | |
| SCHEMBL25402822 | 0.81 | POLRMT (0.51) | POLRMTDOT1L | |
| SCHEMBL30618156 | 0.81 | POLRMT (0.51) | POLRMTDOT1L | |
| SCHEMBL13471155 | 0.81 | POLRMT (0.49) | POLRMTDOT1L | |
| SCHEMBL13471043 | 0.81 | POLRMT (0.49) | POLRMTDOT1L | |
| SCHEMBL20756076 | 0.80 | POLRMT (0.57) | POLRMTDOT1L | |
| SCHEMBL16698968 | 0.80 | POLRMT (0.57) | POLRMTDOT1L | |
| SCHEMBL13486314 | 0.80 | POLRMT (0.55) | POLRMTDOT1L |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705313-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | The Scripps Research Institute (US) | 2026-03-11 | — | — | EP | claimed |
| WO-2024227159-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-10-31 | — | — | WO | claimed |
| EP-4705313-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | The Scripps Research Institute (US) | 2026-03-11 | — | — | EP | disclosed |
| WO-2024227159-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-10-31 | — | — | WO | disclosed |